iRhythm Holdings, Inc. (IRTC) Stock Analysis
Falling Knife setup
Healthcare · Medical Devices
Sell if holding. Momentum 2.1/10 is below the 5.0 floor at $114.00 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: iRhythm Services; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0).
iRhythm provides ambulatory cardiac monitoring services using its Zio patch biosensors (up to 14-day continuous wear) and proprietary cloud-based ZEUS analysis software via Medicare-enrolled IDTFs. It is the market leader delivering over 70% of LTCM services in the U.S.; ~24% of... Read more
Sell if holding. Momentum 2.1/10 is below the 5.0 floor at $114.00 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: iRhythm Services; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0). Chart setup: Death cross, below all MAs, RSI 37, MACD bearish. Score 5.6/10, moderate confidence.
Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 75d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
Recent Developments — iRhythm Holdings, Inc.
Latest news
- Here's why you should retain IRTC stock in your portfolio for now - MSN — MSN positive
- IRTC (iRhythm Holdings Inc.) delivers massive Q4 2025 EPS beat against analyst estimates, stock rises modestly in daily — Cổng thông tin điện tử tỉnh Tây Ninh positive
- Is It Time To Reassess iRhythm Holdings (IRTC) After Recent Share Price Rebound - Yahoo Finance — Yahoo Finance positive
- How New Zio Data and iRhythm Academy Could Shape iRhythm Holdings’ (IRTC) Cardiac Care Strategy - Sahm — Sahm positive
- iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance — Yahoo Finance positive
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHProductiRhythm Services10-K Item 1A: 'Our current revenue is dependent on orders for our iRhythm Services, and we expect that reimbursement for our iRhythm Services will account for substantially all our revenue for the foreseeable future.'
- LOWregulatoryMedicare program (CMS)24%10-K Item 1A: 'During the year ended December 31, 2025, we received approximately 24% of our total revenue from the Medicare program through CMS.'
Material Events(8-K, last 90d)
- 2026-04-01Item 4.01HIGHPricewaterhouseCoopers LLP dismissed as independent registered public accounting firm on March 30, 2026. No disagreements or reportable events in PwC audit reports for FY2025 and FY2024. Successor auditor not named in this filing.SEC filing →
- 2026-03-12Item 5.02LOWJason Patten appointed as director and Audit Committee member effective March 12, 2026, for term expiring at 2026 Annual Meeting. Board determined Patten is independent under Nasdaq standards.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers·1 ceiling hit
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 2.1/10 is below the 5.0 floor at $114.00 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: iRhythm Services; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0). Chart setup: Death cross, below all MAs, RSI 37, MACD bearish. Prior stop was $109.12. Score 5.6/10, moderate confidence.
Take-profit target: $160.20 (+40.5% upside). Prior stop was $109.12. Stop-loss: $109.12.
Concentration risk — Product: iRhythm Services; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0); Leverage penalty (D/E 4.5): -1.5.
iRhythm Holdings, Inc. trades at a P/E of N/A (forward 109.3). TrendMatrix value score: 6.8/10. Verdict: Sell.
21 analysts cover IRTC with a consensus score of 4.3/5. Average price target: $184.
What does iRhythm Holdings, Inc. do?iRhythm provides ambulatory cardiac monitoring services using its Zio patch biosensors (up to 14-day continuous wear)...
iRhythm provides ambulatory cardiac monitoring services using its Zio patch biosensors (up to 14-day continuous wear) and proprietary cloud-based ZEUS analysis software via Medicare-enrolled IDTFs. It is the market leader delivering over 70% of LTCM services in the U.S.; ~24% of 2025 revenue came from Medicare.